Open AccessInduction chemotherapy (IC) followed by radiotherapy (RT) vs. cetuximab plus IC and R in resectable advanced laryngeal/hypopharyngeal cancer (LHSCC) – final results from the randomized DeLOS-II trial
Author(s) -
Andreas Dietz,
Rudolf Hagen,
Dirk Eßer,
Frank Schreiber,
V. Schilling,
M. Jungehülsing,
Juergen Strutz,
U. Schröder,
Ulrich Keilholz,
Gunnar Wichmann
Publication year - 2018
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0038-1640003
Subject(s) - hypopharyngeal cancer , cetuximab , medicine , laryngectomy , induction chemotherapy , larynx , radiation therapy , chemotherapy , randomized controlled trial , cancer , oncology , surgery , colorectal cancer